Duration of Follow Up for New Molecular Entities Approved in 2011

Basic Details
Date Posted
Friday, April 16, 2021
Status
Complete
Medical Product
new molecular entities (NMEs)
Description

In this report we described baseline characteristics and the duration of follow-up time among new users of 30 new molecular entities (NMEs) approved in 2011 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).